KOMBINATIONSPRODUKT BESTEHEND AUS EINEM INHIBITOR DER SRC FAMILIE DER NICHT-REZEPTOR TYROSINKINASEN UND GEMCITABIN ZUR BEHANDLUNG ODER PROPHYLAXE VON PANKREASKREBS

摘要

The invention concerns a combination comprising an inhibitor of Src kinase and the cytotoxic agent gemcitabine, a pharmaceutical composition comprising such a combination and its use in the treatment or prophylaxis of cancer, particularly of pancreatic cancer.